https://www.selleckchem.com/pr....oducts/vacuolin-1.ht
A simplified Canadian definition was recently developed to enable identification of individuals with familial hypercholesterolemia (FH) and severe hypercholesterolemia in the general population. Our objective was to use a modified version of this new definition to assess contemporary disease prevalence, treatment patterns, and low-density lipoprotein cholesterol (LDL-C) control in Ontario, Canada. We identified individuals aged 66 to 105 years who were alive as of January 1, 2011, using the rdiovascular alth in mbulatory Care esearch